Scientists Halt Cancer Spread Breakthrough
- Researchers have identified a protein, SPP1, that plays a crucial role in the spread of pancreatic cancer.
- * SPP1 Levels & Cancer stage: Higher levels of SPP1 were found in advanced pancreatic cancer tumors compared to earlier stages.
- This research suggests that SPP1 could be a promising target for new drug treatments for pancreatic cancer.
Here’s a summary of the article, focusing on the key findings:
Researchers have identified a protein, SPP1, that plays a crucial role in the spread of pancreatic cancer.
Key Findings:
* SPP1 Levels & Cancer stage: Higher levels of SPP1 were found in advanced pancreatic cancer tumors compared to earlier stages.
* SPP1 & Patient Outcomes: Patients with higher SPP1 levels had worse outcomes.
* Blocking SPP1: “Switching off” the gene that produces SPP1 in lab-grown tumors resulted in fewer and smaller tumors.
* SPP1 in Mice: In mice with pancreatic cancer, blocking SPP1 substantially extended survival (20% survived to 400 days vs. none surviving past 50 days) and prevented tumor spread.
Implications:
This research suggests that SPP1 could be a promising target for new drug treatments for pancreatic cancer. Blocking this protein could potentially slow or stop the cancer’s progression and improve patient survival.
Funding:
The research was funded by the Institute of Cancer Research (ICR) and Breast Cancer Now.